feed,title,long_url,short_url
MedRxiv,2-Deoxy-D-Glucose as an Adjunct to Standard of Care in the Medical Management of COVID-19: A Proof-of-Concept & Dose-Ranging Randomised Clinical Trial,https://medrxiv.org/cgi/content/short/2021.10.08.21258621v1?rss=1,https://j.mp/3BAjL7W
MedRxiv,Clinical Benefits and Budget Impact of Lenzilumab plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with COVID-19 in the United States from the Hospital Perspective,https://medrxiv.org/cgi/content/short/2021.10.06.21264651v1?rss=1,https://j.mp/3BvORO2
